For following the competition: what moved in each program, several studies read as one move.
- lorigerlimab
- Anti-ADAM9/Exatecan Antibody-drug Conjugate MGC028
- MGC030
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add MacroGenics to watchlistEvery Monday by email · turn it off any timePro · free during the beta